Today's news that Mundipharma has been appointed partner for flutiform® in Mexico, Central and South America expands on its partnership already in place with Skyepharma for the product. The relationship has proven to be very successful to date with flutiform® continuing to generate substantial growth, as highlighted by the recent recognition of a €10m sales milestone. The transfer of the exclusive rights from Sanofi to Mundipharma in this region has been undertaken on the same terms as establish ....
28 Jan 2016
Mundipharma appointed partner for flutiform® in Latin America
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Mundipharma appointed partner for flutiform® in Latin America
SkyePharma (SKP:LON) | 0 0 0.0% | Mkt Cap: 470.3m
- Published:
28 Jan 2016 -
Author:
Sheena Berry -
Pages:
3
Today's news that Mundipharma has been appointed partner for flutiform® in Mexico, Central and South America expands on its partnership already in place with Skyepharma for the product. The relationship has proven to be very successful to date with flutiform® continuing to generate substantial growth, as highlighted by the recent recognition of a €10m sales milestone. The transfer of the exclusive rights from Sanofi to Mundipharma in this region has been undertaken on the same terms as establish ....